Insurance Guide · Updated August 2026

How to Get Insurance to Cover GLP-1 Medications in 2026

Brand-name Wegovy costs $1,349/month at list price. Zepbound costs $1,086/month. Eligible commercially insured patients may pay as little as $25 with a manufacturer savings offer, and eligible Medicare Part D beneficiaries can now access certain weight-management GLP-1s for a $50 monthly copay through the Medicare GLP-1 Bridge. The actual amount depends on the drug, diagnosis, plan, prior authorization, and program terms.

Which Insurers Cover GLP-1s for Weight Loss?

Coverage varies dramatically by insurer, plan type, employer, diagnosis, and formulary. Here is the general picture as of August 2026:

Key distinction: Ozempic and Mounjaro are approved for type 2 diabetes. Wegovy and Zepbound are approved for weight management. Insurance coverage is generally better for the diabetes indications. If you have type 2 diabetes, your path to coverage is much simpler. For a clinical comparison of these medications, see our Mounjaro vs Ozempic breakdown.

Important trend: Employer plans continue to add, restrict, or remove anti-obesity drug benefits. An insurer’s brand name alone does not establish coverage because two employer groups using the same insurer can have different formularies. Check your specific plan before assuming you are covered.

Step-by-Step: Getting Prior Authorization Approved

Many plans require prior authorization (PA) before covering GLP-1 medications for weight management. Here is the general process:

Step 1: Confirm Your Plan Covers GLP-1s

Call the number on the back of your insurance card. Ask specifically: “Does my plan cover Wegovy (or Zepbound) for weight management?” Get the answer in writing if possible. If they say no, skip to the manufacturer savings section below.

Step 2: Meet the Clinical Criteria

Common criteria can include:

• BMI of 30 or higher, OR BMI of 27+ with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea)
• Documentation of prior weight-management efforts when the plan’s written criteria require it
• No label contraindications such as a personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, or a prior serious hypersensitivity reaction to the medication. A history of pancreatitis may prompt additional clinical review but is not listed as a formal contraindication in the current Ozempic or Mounjaro labels.

Tips:

• If your doctor has not documented your BMI and weight-related conditions in your medical record, ask them to do so at your next visit. Prior auth reviewers look at your chart.
• Some plans require step therapy. Ask which alternatives, durations, contraindications, or prior trials satisfy the written rule.

Step 3: Your Doctor Submits the Prior Auth

Your prescribing physician (or a telehealth platform like Ro or Calibrate that handles insurance) submits the PA request. This includes:

• Your diagnosis (obesity, overweight with comorbidities)
• Clinical rationale for GLP-1 medication
• Documentation of prior weight loss attempts
• Relevant lab work (BMI, A1C, lipid panel)

Step 4: Wait (and Follow Up)

Decision deadlines vary by plan, request type, and governing law. Ask the insurer for the standard and expedited deadlines that apply to this request, keep the submission reference number, and follow up if that stated deadline passes.

Step 5: If Approved

Your pharmacy fills the prescription. Your copay depends on your plan. Manufacturer savings cards (see below) can reduce copays further.

Step 6: If Denied

Do not give up. See the appeal section below.

What to Do When You Get Denied

If a GLP-1 prior authorization is denied, use the reason in the written notice to decide whether missing documentation, a formulary exclusion, step therapy, or another plan rule can be appealed.

Level 1: Internal Appeal

• Request a copy of the denial letter and identify the stated reason, cited criterion, and next review or appeal step.
• Your doctor writes a letter of medical necessity explaining why this specific medication is needed for your health.
• Include supporting documentation: lab results, BMI history, comorbidity documentation, failed prior treatments.
• If the denial cites missing or incorrect documentation, submit the specific records needed to address that reason.

Level 2: Peer-to-Peer Review

• Your doctor can request a peer-to-peer review, where they speak directly with the insurer’s medical director.
• This is often more effective than written appeals because your doctor can make the clinical case in real-time.

Level 3: External Review

• If internal appeals fail, you can request an independent external review through your state’s insurance department.
• The external reviewer is not employed by your insurer and makes an independent determination.

Level 4: State Insurance Commissioner

• File a complaint with your state’s insurance commissioner if you believe the denial was improper.
• This is a last resort but can be effective, especially if the denial contradicts the insurer’s own published formulary criteria.

Reliable national GLP-1-specific appeal success rates are not published. An appeal is still worth considering when the denial resulted from missing records, an incorrect diagnosis code, or a plan criterion the submitted documentation actually satisfies.

Manufacturer Savings Programs

Even with insurance, your copay can be high. Manufacturer savings cards can reduce it:

Wegovy (Novo Nordisk)

• Wegovy Savings Offer: Eligible commercially insured patients may pay as little as $25/month, subject to a $100 monthly savings cap
• NovoCare self-pay: Wegovy tablets start at $149 for the 1.5mg and 4mg doses under the current time-limited offer. New eligible injection patients pay $199/month for their first two fills of the 0.25mg or 0.5mg pen through December 31, 2026; standard injection self-pay is $349/month and Wegovy HD is $399/month
• Verify current eligibility and terms on NovoCare

Zepbound (Eli Lilly)

• Zepbound Savings Card: Eligible commercially insured patients with coverage may pay as little as $25/month
• Zepbound self-pay: $299/month for 2.5mg and $399/month for 5mg. Doses from 7.5mg through 15mg may be $449/month through the Journey Program when refilled within 45 days; regular prices are higher.
• Verify current eligibility and terms on Lilly’s Zepbound savings page
• Savings card not valid for government insurance (Medicare, Medicaid, Tricare)

Ozempic (Novo Nordisk)

• Ozempic Savings Card: Eligible commercially insured patients with coverage may pay as little as $25/month, subject to program limits
• Note: Ozempic is approved for type 2 diabetes. Using it for weight loss is off-label and may affect insurance coverage.

Mounjaro (Eli Lilly)

• Mounjaro Savings Card: Eligible commercially insured patients with coverage may pay as little as $25 for up to a 3-month prescription; eligible commercially insured patients without coverage may pay as low as $499 for a 1-month fill
• Approved for type 2 diabetes. Weight loss use is off-label.

Eligibility: Copay-card benefits typically require commercial insurance and cannot be processed with Medicare, Medicaid, Tricare, or other government-funded insurance. A separate manufacturer self-pay offer may still be available when the purchase is processed entirely outside government benefits; it will not count toward the plan’s deductible or out-of-pocket limit.

HSA and FSA for GLP-1 Medications

GLP-1 medications prescribed for a diagnosed medical condition (obesity, type 2 diabetes) are generally eligible for HSA and FSA reimbursement.

What qualifies:

• The prescription itself (medication cost)
• Doctor visit copays related to GLP-1 treatment
• Lab work ordered as part of treatment
• Telehealth platform membership fees (if treating a medical condition)

What you need:

• A prescription and itemized receipt; an administrator may also request a Letter of Medical Necessity
• Receipts for all expenses
• Check with your specific HSA/FSA administrator for their requirements

Our provider records list direct HSA/FSA acceptance for Ro, Hims, MEDVi, SkyRx, Eden, and Found. Verify at checkout because card acceptance and the eligibility of each bundled charge can change.

Medicare and GLP-1s in 2026

Medicare access changed on July 1, 2026. The Medicare GLP-1 Bridge now gives eligible beneficiaries with Part D coverage access to Foundayo, all Wegovy formulations, and the Zepbound KwikPen for weight management at a $50 monthly copay. The temporary nationwide program runs through December 31, 2027 and requires prior authorization.

The Bridge is separate from normal Part D coverage. People whose prescription is already coverable under the standard Part D benefit for another FDA-approved indication, such as Ozempic or Mounjaro for type 2 diabetes, Wegovy for cardiovascular risk reduction in eligible adults, or Zepbound for qualifying obstructive sleep apnea, use their Part D coverage rather than the Bridge.

Not every Medicare beneficiary qualifies. Review the clinical criteria at CMS or call 1-800-MEDICARE before assuming a drug is covered.

Platforms That Handle Insurance for You

Not all telehealth platforms handle insurance. Here is who does:

If insurance coverage matters to you, Calibrate and Ro are the strongest options for handling the prior authorization process.

The Bottom Line

The difference between an eligible $25 commercial savings-card price, a $50 Medicare Bridge copay, and several hundred dollars in cash-pay cost can add up quickly. Check the exact plan and diagnosis rules first, document the medical history accurately, and use the denial reason to decide whether an appeal is appropriate.

If insurance does not cover the prescribed product, compare manufacturer self-pay routes and FDA-approved alternatives first. Patient-specific compounding may be considered only when a licensed prescriber determines that an available approved drug cannot meet the identified medical need and all legal conditions are satisfied. See our compounded vs brand-name guide and cheapest GLP-1 guide for the tradeoffs. Our GLP-1 without insurance guide covers cash-pay paths in detail.

FAQ

Does insurance cover Wegovy for weight loss?

Some commercial insurance plans cover Wegovy for weight management with prior authorization. Coverage varies by insurer, plan type, and employer. Eligible Medicare Part D beneficiaries may also obtain Wegovy for weight management through the Medicare GLP-1 Bridge for a $50 monthly copay.

How long does prior authorization take for GLP-1 medications?

Timing varies by plan, request type, and governing law. Ask the insurer for the applicable standard and expedited deadlines, retain the submission reference number, and follow up if its stated deadline passes.

What if my insurance denies GLP-1 coverage?

Appeal when the denial appears inconsistent with your plan criteria or resulted from missing documentation. Request the denial letter, have your clinician supply the relevant records and medical rationale, and request a peer-to-peer or external review if applicable. Reliable national GLP-1-specific appeal success rates are not published.

Can I use an HSA or FSA for GLP-1 medications?

Yes, when prescribed for a diagnosed medical condition (obesity, type 2 diabetes). You will need a Letter of Medical Necessity from your prescribing physician. Both the medication cost and related medical expenses (doctor visits, lab work, telehealth membership fees) may qualify. Check with your specific HSA/FSA administrator.

Does Medicare cover Mounjaro or Ozempic?

Medicare Part D can cover Mounjaro and Ozempic for type 2 diabetes and other drugs for coverable FDA-approved indications. Since July 1, 2026, eligible Part D beneficiaries can also access Wegovy, Zepbound KwikPen, or Foundayo for weight management through the separate Medicare GLP-1 Bridge for a $50 monthly copay.

Related

Guides:

• Cheapest GLP-1 Online · Insurance Coverage · Side Effects
• Mounjaro Dosage Guide · Oral vs Injectable · Exercise and Muscle
• Compounded vs Brand-Name · Without Insurance
• Fat Loss vs Weight Loss · DEXA Scan Results · Mounjaro Plateau · Medicare Coverage · Wegovy Pill vs Injection

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Tools: GLP-1 Cost Estimator · Body Composition Calculator

Compare: All Providers · Best GLP-1 Programs · Insurance Programs · All Guides